Table 9 |
||||
|
Regression analysis of initial glutathione and change in glutathione (from before and after phase 1). |
||||
|
Adjusted R2 |
P-Value |
Equation |
Most Significant variables |
|
|
|
||||
|
Glutathione (n = 59) |
0.25 |
0.003 |
378.7-48.8 PbB + 3.67AsB -219 CdB +2.49 Sn9 +369 TlB -69.9 Hg9 -4.32 As9 +598 Cd9 |
Cd9**, PbB*, Sn9*, Tl9*, As9* |
|
Change in glutathione (n = 37) |
0.29 |
0.002 |
104-2.26Sn9+87.8Hg9-669Cd9 |
Cd** |
|
|
||||
|
The analysis involved metals at Baseline (B) and after the 9th dose (9). |
||||
|
Adams et al. BMC Clinical Pharmacology 2009 9:16 doi:10.1186/1472-6904-9-16 |
||||
